The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Phase 2 study of pembrolizumab (pembro) monotherapy for previously treated metastatic triple-negative breast cancer (mTNBC): KEYNOTE-086 cohort A.
 
Sylvia Adams
No Relationships to Disclose
 
Peter Schmid
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Celgene; Eisai; Genentech/Roche (I); Merck; Novartis; Pfizer; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); Oncogenex (Inst)
 
Hope S. Rugo
Honoraria - Genomic Health
Speakers' Bureau - Genomic Health
Research Funding - Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Leap Therapeutics; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Delphine Loirat
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - BMS Brazil; Merck Sharp & Dohme; Roche
 
Ahmad Awada
No Relationships to Disclose
 
David W. Cescon
Consulting or Advisory Role - Genomic Health
Research Funding - GlaxoSmithKline; Merck; Novartis; Roche
 
Hiroji Iwata
No Relationships to Disclose
 
Mario Campone
Honoraria - AstraZeneca; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Sanofi
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Rita Nanda
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche; Novartis; Peregrine Pharmaceuticals; Pfizer; Puma Biotechnology
Research Funding - Celgene; Corcept Therapeutics; Merck
 
Rina Hui
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Novartis; Pfizer
 
Giuseppe Curigliano
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Deborah Toppmeyer
Employment - Novartis (I)
Leadership - Novartis (I)
Stock and Other Ownership Interests - Novartis (I)
 
Joyce O'Shaughnessy
Honoraria - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Celgene; Eisai; Genentech/Roche; Lilly; Nektar; Novartis; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Lilly; Nektar; Novartis; Pfizer
 
Sherene Loi
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - PI3K pathway gene signature granted by the European and US patent offices (Inst)
 
Shani Paluch-Shimon
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
 
Deborah Card
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Jing Zhao
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Vassiliki Karantza
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Celgene; Cellestia Biotech; Roche/Genentech